Comparable outcomes between Besifovir and other antiviral therapies in hepatocellular carcinoma development among patients with chronic hepatitis B

被引:0
|
作者
Lee, Jae Seung [1 ]
Lee, Won [2 ]
Kim, Sang Gyune [3 ]
Seo, Yeon Seok [4 ]
Yu, Su Jong [5 ,6 ]
Yim, Hyung Joon [7 ]
Lee, Hye Won [1 ]
Kim, Mi Na [1 ]
Kim, Beom Kyung [1 ]
Park, Jun Yong [1 ]
Kim, Do Young [1 ]
Ahn, Sang Hoon [1 ]
Kim, Seung Up [1 ]
机构
[1] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[2] Catholic Univ Korea, Bucheon St Marys Hosp, Dept Internal Med, Sch Med, Bucheon, South Korea
[3] Soonchunhyang Univ, Coll Med, Dept Internal Med, Bucheon Hosp, Bucheon, South Korea
[4] Korea Univ, Coll Med, Dept Internal Med, Anam Hosp, Seoul, South Korea
[5] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[6] Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea
[7] Korea Univ, Coll Med, Div Gastroenterol & Hepatol, Dept Internal Med,Ansan Hosp, Ansan, South Korea
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
WED-404
引用
收藏
页码:S799 / S799
页数:1
相关论文
共 50 条
  • [21] Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B
    Chon, Hye Yeon
    Lee, Jae Seung
    Lee, Hye Won
    Chun, Ho Soo
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Seung Up
    HEPATOLOGY RESEARCH, 2021, 51 (04) : 406 - 416
  • [22] Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
    Shin, Jung Woo
    Jeong, Joonho
    Jung, Seok Won
    Lee, Seung Bum
    Park, Bo Ryung
    Kim, Min-Ju
    Park, Eun Ji
    Park, Neung Hwa
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (05) : 1739 - 1750
  • [23] Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
    Jung Woo Shin
    Joonho Jeong
    Seok Won Jung
    Seung Bum Lee
    Bo Ryung Park
    Min-Ju Kim
    Eun Ji Park
    Neung Hwa Park
    Digestive Diseases and Sciences, 2021, 66 : 1739 - 1750
  • [24] Association between Hepatic Steatosis and the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
    Lee, Yun Bin
    Ha, Yeonjung
    Chon, Young Eun
    Lee, Ju Ho
    Park, Hana
    Sr, Jung-Hwan Yoon
    Hwang, Seong-Gyu
    HEPATOLOGY, 2018, 68 : 1201A - 1202A
  • [25] Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
    Lee, Yun Bin
    Ha, Yeonjung
    Chon, Young Eun
    Kim, Mi Na
    Lee, Joo Ho
    Park, Hana
    Kim, Kwang-il
    Kim, Soo-Hwan
    Rim, Kyu Sung
    Hwang, Seong Gyu
    CLINICAL AND MOLECULAR HEPATOLOGY, 2019, 25 (01) : 52 - 64
  • [26] Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
    Lee, Y. B.
    Ha, Y.
    Chon, Y. E.
    Kim, M. N.
    Lee, J. H.
    Park, H.
    Rim, K. S.
    Hwang, S. G.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S503 - S503
  • [27] Hepatocellular carcinoma among patients with chronic hepatitis B in the indeterminate phase
    Mak, Lung-Yi
    Yee, Leland J.
    Wong, Robert J.
    Ramers, Christian B.
    Frenette, Catherine
    Hsu, Yao-Chun
    JOURNAL OF VIRAL HEPATITIS, 2024, 31 : 27 - 35
  • [28] Antiplatelet Therapy and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Antiviral Treatment
    Lee, Minjong
    Chung, Goh Eun
    Lee, Jeong-Hoon
    Oh, Sohee
    Nam, Joon Yeul
    Chang, Young
    Cho, Hyeki
    Ahn, Hongkeun
    Cho, Young Youn
    Yoo, Jeong-ju
    Cho, Yuri
    Lee, Dong Hyeon
    Cho, Eun Ju
    Yu, Su Jong
    Lee, Dong Ho
    Lee, Jeong Min
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    HEPATOLOGY, 2017, 66 (05) : 1556 - 1569
  • [29] The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
    Varbobitis, Ioannis
    Papatheodoridis, George V.
    CLINICAL AND MOLECULAR HEPATOLOGY, 2016, 22 (03) : 319 - 326
  • [30] Adherence to initiation of antiviral therapy and hepatocellular carcinoma screening among patients with hepatitis B
    Lucas, S.
    Tripp, E.
    Gazelakis, K.
    Byers, S.
    Rouse, S.
    Ng, D. Y. L.
    Kronborg, I.
    Burns, G.
    Srivasta, G.
    Sandhu, D.
    Quach, T.
    Valaydon, Z.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 90 - 90